全文获取类型
收费全文 | 2108篇 |
免费 | 127篇 |
国内免费 | 94篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 6篇 |
妇产科学 | 135篇 |
基础医学 | 270篇 |
口腔科学 | 9篇 |
临床医学 | 167篇 |
内科学 | 362篇 |
皮肤病学 | 6篇 |
神经病学 | 7篇 |
特种医学 | 98篇 |
外科学 | 358篇 |
综合类 | 199篇 |
预防医学 | 35篇 |
眼科学 | 11篇 |
药学 | 62篇 |
1篇 | |
中国医学 | 5篇 |
肿瘤学 | 568篇 |
出版年
2024年 | 1篇 |
2023年 | 44篇 |
2022年 | 85篇 |
2021年 | 92篇 |
2020年 | 64篇 |
2019年 | 65篇 |
2018年 | 63篇 |
2017年 | 72篇 |
2016年 | 63篇 |
2015年 | 84篇 |
2014年 | 159篇 |
2013年 | 138篇 |
2012年 | 122篇 |
2011年 | 134篇 |
2010年 | 108篇 |
2009年 | 117篇 |
2008年 | 111篇 |
2007年 | 104篇 |
2006年 | 111篇 |
2005年 | 77篇 |
2004年 | 54篇 |
2003年 | 44篇 |
2002年 | 41篇 |
2001年 | 41篇 |
2000年 | 32篇 |
1999年 | 34篇 |
1998年 | 31篇 |
1997年 | 24篇 |
1996年 | 23篇 |
1995年 | 30篇 |
1994年 | 25篇 |
1993年 | 15篇 |
1992年 | 14篇 |
1991年 | 12篇 |
1990年 | 8篇 |
1989年 | 11篇 |
1988年 | 9篇 |
1987年 | 12篇 |
1986年 | 7篇 |
1985年 | 11篇 |
1984年 | 5篇 |
1983年 | 4篇 |
1982年 | 8篇 |
1981年 | 8篇 |
1980年 | 7篇 |
1979年 | 1篇 |
1977年 | 3篇 |
1976年 | 1篇 |
排序方式: 共有2329条查询结果,搜索用时 0 毫秒
1.
2.
3.
A Donna P G Betta D Bellingeri F Tallarida M Pavesi M Pastormerlo 《Diagnostic cytopathology》1992,8(4):361-365
Differentiating mesothelioma, reactive mesothelium, and adenocarcinoma in serous effusions is often difficult, despite the application of ancillary techniques in support of the traditional cytomorphologic criteria. A polyclonal antimesothelial-cell antibody recently developed by our group was evaluated as a histogenetic marker on a series of primary (n = 12) and metastatic (n = 12) malignant effusions. Immunostaining was performed on paraffin sections from cell blocks. All mesothelioma effusions stained positive for the antibody, whereas, in contrast, all metastatic carcinoma specimens failed to react. These results (100 percent specificity and 100% sensitivity for mesothelioma) provide a basis for a reliable use of the antibody in the cytologic examination of suspicious or malignant serous effusions. 相似文献
4.
Barbara S. Ducatman Helen H. Wang Jon G. Jonasson Christine L. Hogan Donald A. Antonioli Gladwyn Leiman 《Diagnostic cytopathology》1993,9(1):98-105
Tubal metaplasia of the endocervix (TME), a condition that may be con/used morphologically with glandular neoplasia, is frequently found in cone or hysterectomy specimens. To determine the frequency of detecting TME in cytologic smears, we retrospectively reviewed 28 Papanicolaou (Pap) smears from 22 women (mean age 39.1 yr; range 25-60 yr) with histologically proven TME. Our criteria for TME were the presence of two cell types in addition to endocervical secretory cells, i.e., peg cells (cells with dark and granular cytoplasm and elongate nuclei) and ciliated cells. All women had cervical cytology specimens obtained with an endocervical brush shortly before the procedures in which TME was diagnosed, and five also had at least one post-procedure smear. Of 20 smears with an adequate, non-neoplastic endocervical component, TME was found in 2 (10%). In these two, TME cells constituted 10% and < 5% of all the glandular cells, respectively, and the percentage of ciliated cells in the TME was approximately 25% and 75%. In conclusion, TME was noted infrequently (10%) on the cervical cytosmears of women with histologically-proven TME. This result corresponds to the histologic finding that TME typically involves the upper endocervix and glandular epithelium, with only 13% of the women having TME on the surface of the lower endocervix. Atypical glandular cells on cervical cytology are a problem for clinicians and pathologists alike. The differential diagnosis of such atypia, including TME, cells of the lower uterine segment, squamous intraepithelial lesion in glands and glandular neoplasia, is discussed. 相似文献
5.
Expression of cyclin D1, retinoblastoma gene protein, and p16 MTS1 protein in atypical adenomatous hyperplasia and adenocarcinoma of the lung 总被引:2,自引:0,他引:2
Y. Kurasono Takaaki Ito Yoichi Kameda Nobuo Nakamura Hitoshi Kitamura 《Virchows Archiv : an international journal of pathology》1998,432(3):207-215
To clarify the events leading to the disruption of cell growth control that occurs during the development of pulmonary adenocarcinoma
(AC), we used immunohistochemistry to evaluate the expression of G1 cycle regulators, cyclin D1, Rb protein (pRb), and p16
MTS1 protein and the tumour proliferation marker, Ki 67, both in AC of the lung and in its precursor lesion, atypical adenomatous
hyperplasia (AAH). The frequency of lesions with cyclin D1 overexpression was relatively high in AAH (47–89%), but was decreased
in early AC (28%) and overt AC (35%). The loss of pRb expression was rare in both AAH (0–18%) and early AC (0%), and was infrequent
even in overt AC (13%). The loss of p16 expression was also relatively infrequent in both the premalignant and the malignant
lesions (11–25%). Our results suggest that overexpression of cyclin D1 is an early event and plays an important part in tumorigenesis
in the case of lung AC. However, cyclin D1 overexpression is not required for the development and maintenance of a malignant
phenotype. It is likely that some cyclin D1-independent pathways other than Rb and p16 abnormalities have an important role
in the malignant transformation from AAH to early AC.
Received: 8 July 1997 / 26 September 1997 相似文献
6.
Valeria Ascoli Silvia Taccogna Caterina Carnovale Scalzo Francesco Nardi 《Diagnostic cytopathology》1995,12(4):303-308
Using a commercially available monoclonal antibody (Ks20.1) and the avidin-biotin peroxidase method on cytospins and cell blocks, we analyzed cytokeratin (CK) 20 expression in 169 serous effusions. Cytoplasmic staining was observed in 44/151 malignant fluids. Colon, gastric, and pancreatic adenocarcinomas and mucinous ovarian tumors were most frequently positive. Single cases of transitional-cell and squamous cell carcinomas were reactive as well. Lung and breast cancers were mostly negative. Nonmucinous ovarian tumors were invariably unlabeled as were mesotheliomas and normal mesothelial cells. the study shows that CK 20 is valuable in distinguishing tumor cell origin in effusions. in particular, it identifies a set of carcinomas with the majority arising from the gastrointestinal tract, and represents a highly characteristic marker for colorectal cancer. © 1995 Wiley- Liss, Inc. 相似文献
7.
奥替普拉诱发人肺腺癌细胞凋亡的研究 总被引:1,自引:0,他引:1
目的探讨奥替普拉(oltipraz)能否诱发人肺腺癌细胞凋亡及其机制。方法应用光镜、DNA电泳、流式细胞仪、活细胞视频观察进行检测和分析。结果癌细胞在奥替普拉作用下,细胞分裂阻滞在分裂中期,G2/M百分比增高,出现细胞凋亡峰,凋亡细胞出现胞体固缩、核染色质凝聚或者断裂,细胞DNA裂解片段呈现典型的“梯形”条带。奥替普拉诱导的GLC细胞凋亡在使用浓度120μg/ml时效果明显。结论奥替普拉在适当浓度时能够诱发人肺腺癌细胞凋亡,这种作用与分裂期阻滞密切相关。 相似文献
8.
上皮性钙粘附蛋白和β-连环素的表达与胆囊腺癌预后的关系 总被引:1,自引:0,他引:1
目的 探讨上皮性钙粘附蛋白 (E cad)及 β 连环素 (β cat)在胆囊腺癌中的表达及其与分化、转移、临床分期和预后的关系。方法 免疫组织化学法 (SP法 )和原位杂交法。结果 免疫组织化学法 :60例胆囊腺癌中E cad及 β cat的阳性率分别为 40 %和 45 % ,异常表达率分别为 58 3 %和 63 3 %。E cad和 β cat的异常表达率与胆囊腺癌的分化程度有相关性 (P <0 0 5) ,在有淋巴结转移病例中E cad及 β cat的异常表达率明显高于无转移病例 ,随着临床分期由Ⅰ期到Ⅳ期 ,E cad及 β cat异常表达率明显增高 (P <0 0 5)。E cad和 β cat异常表达病例的平均生存时间和 5年生存率明显低于正常表达病例。原位杂交法 :胆囊腺癌中E cad和 β catmRNA的阳性率分别为 60 %和 40 % ,与蛋白正常表达一致率分别为 78 8%和 82 4%。结论 检测 β cat或E cad和 β cat的共同表达是指导临床治疗及估计预后有意义的指标 ,可应用临床预后的综合评估 相似文献
9.
目的:检测垂体腺瘤组织中垂体肿瘤转化基因(PTTG)、bFGF mRNA的表达,分析其与垂体腺瘤侵袭性的关系及临床意义。方法:应用逆转录PCR(RT—PCR)方法检测30例垂体腺瘤组织标本中PTTG、bFGF mRNA的表达,分析二者与垂体腺瘤侵袭性的关系。结果:侵袭性垂体腺瘤组的PTTG、mRNA表达、bFGF mRNA表达均较非侵袭性腺瘤组增高,其差异具有统计学意义。结论:垂体腺瘤侵袭性的发生与垂体肿瘤转化基因(PTTG)表达增高及其上调血管生成正调节因子bFGF并表达、促进血管生成有关, 相似文献
10.
联合检测E-cadherin、CEA及Calretinin在浆膜腔积液细胞学鉴别诊断中的意义 总被引:2,自引:0,他引:2
背景与目的:浆膜腔积液中转移性腺癌细胞、恶性上皮型间皮瘤细胞和反应性间皮细胞的形态有不少相似之处,有时仅凭形态学特征不能做出准确诊断。近年来免疫细胞化学在这方面得到较多应用,但国内报道仅局限于用CK、EMA、CEA、Vim和HBME-1几种抗体,而且不能较好地进行细胞学的鉴别诊断。本研究旨在探讨联合检测E-cadherin、CEA及calretinin在浆膜腔积液鉴别诊断中的应用价值。方法:选用浆膜腔积液标本共93例,其中胸水66例、腹水24例、心包积液3例。经组织学检查或结合临床资料证实的转移性腺癌55例、恶性上皮型间皮瘤6例、间皮细胞反应性增生32例。每例均制备HE染色的涂片和细胞块,并用细胞块切片作免疫细胞化学染色。结果:E-cadherin、CEA对诊断转移性腺癌的敏感性分别为85.5%(47/55)、78.2%(43/55),特异性分别为100%(38/38)、97.4%(37/38)。E-cadherin和CEA联合应用诊断浆膜腔积液转移性腺癌的阳性率为96.4%(53/55)。Calretinin对诊断间皮瘤和间皮细胞增生的敏感性和特异性分别为81.6%(31/38)和87.2%(48/55)。结论:E-cadherin、CEA和calretinin是鉴别浆膜腔积液转移性腺癌细胞和间皮源性细胞有价值的一组抗体。 相似文献